Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Castillo I, Bartolomé J, Ruiz-Moreno M, Sánchez V, Navas S,Carreño V. Pediatric Res 1995; 38: 618-620.
Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon alpha
Pardo M, Castillo I, Navas S,Carreño V. J Med Virol 1995; 45: 439-444.
Biologic response modifiers in chronic hepatitis C
Carreño V, Quiroga JA. J Hepatol 1995; 22: s122-s126.
Semiquantification by Amplicor TM assay of hepatitis C virus genome during therapy
Navas S,Carreño V. J Hepatol 1995; 22: s115-s117.
Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C
González S, Navas S, Madejón A, Bartolomé J, Castillo I, Moraleda G, Martín J, Marriott E, Herrero M,Carreño V. J Med Virol 1995; 45: 168-173.
Porphyria cutanea tarda and hepatitis C and B viruses infection: A retrospective study.
Navas S, Bosch O, Castillo I, Marriott E,Carreño V. Hepatology 1995; 21: 279-284.
Sequence of non-structural regions 3 and 5 of hepatitis C virus genomes from Spanish patients: existence of a predominant variant related to type 1b
Pernas M, Bartolomé J, Castillo I, Quiroga JA, Pardo M,Carreño V.J Gen Virol 1995; 76: 415-420.
Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity and liver disease outcome.
Quiroga JA, van Binsbergen J, Wang CY, Pardo M, Navas S, Trines Ch, Herrero M,Carreño V. Hepatology 1995; 22: 1635-1640.
Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication and liver disease outcome in chronic hepatitis C.
Quiroga JA, Herrero M, Castillo I, Navas S, Pardo M,Carreño V. J Infect Dis 1994; 170: 669-673.
Lack of efficacy of inosine pranobex in the treatment of chronic hepatitis C
Pardo,Carreño V. J Hepatol 1994; 21: 278.
Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: Relation with the liver lesion.
Navas S, Castillo I, Bartolomé J, Marriott E, Herrero M,Carreño V. J Hepatol 1994; 21: 182-186.
Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to alpha-interferon
Quiroga JA, Martín J, Pardo M,Carreño V. Dig Dis Sci 1994; 39: 2485-2496.